Royal DSM has announced that it has reached an agreement to acquire the flavor and fragrance (F&F) bio-based intermediates business of Amyris, Inc.
Related: DSM Launches CirculariTeam Coalition
The acquisition extends DSM’s offerings in aroma ingredients with bio-based ingredients for the flavor and fragrance and cosmetics industries.
DSM will acquire the business for an upfront consideration of $150 million and Amyris will share in the EBITDA growth over the period 2021-2024 of certain of the activities.
Acquiring the entire F&F business from Amyris is synergetic for DSM, as it:
Further strengthens DSM’s biotechnology base with F&F intermediate products and increases the scale of DSM’s biotechnology activities in nutritional ingredients.
Broadens DSM’s existing offerings in aroma ingredients with additional biotechnology-based products for DSM’s F&F customer base.
Strengthens DSM’s sustainability profile further, as bio-based F&F ingredients offer additional alternatives to chemistry-based products as well as botanically-sourced ingredients.
Gareth Barker, president DSM personal care and aroma ingredients, commented, “We are pleased that we can extend the offering to our customers with an additional seven important intermediates that will help our flavor and fragrance and cosmetics customers to improve their sustainability profile. These bio-based ingredients provide them with attractive and sustainable additional alternatives.”